Host: E. coli • AA: 398-626 • Tag: N-terminal His • MW: 27.74 kDa
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NR4A3 Ligand-binding Domain (human, recombinant)

Item No. 40344

Technical Information
Synonyms
  • Mitogen-induced Nuclear Orphan Receptor
  • Neuron-derived Orphan Receptor 1
  • Nuclear Hormone Receptor NOR-1
  • Nuclear Receptor Subfamily 4 Group A Member 3
Purity
≥80%
Source
Recombinant human N-terminal His-tagged NR4A3 expressed in E. coli
Amino Acids
398-626
MW
27.74 kDa
50 mM Tris HCl, pH 7.5, with 100 mM sodium chloride, and 2% glycerol
UniProt Accession №
Q92570
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Nuclear receptor subfamily 4 group A member 3 (NR4A3) is a transcription factor and member of the NR4A orphan nuclear receptor family.1,2 It is composed of an N-terminal activation function-1 (AF-1) transactivation domain, a DNA-binding domain, a variable linker region, and a C-terminal domain comprising a ligand-binding domain and an AF-2 domain. NR4A3 is primarily expressed in the fetal brain and lungs and adult heart and skeletal muscle, with both splice variants showing similar expression patterns.3,4 It is involved in several biological processes, including apoptosis, differentiation, metabolism, inflammation, cardiac remodeling, and development, and its expression can be induced by several factors such as growth factors, cytokines, and stress.1,2 Knockout of Nr4a3 inhibits GM-CSF- and IL-4-induced differentiation of primary mouse monocytes into dendritic cells.5 Overexpression of NR4A3 reduces infarct size as a percentage of the area at risk in a mouse model of acute myocardial infarction.6 Fusion proteins of NR4A3 with Ewing sarcoma protein (EWS) or TAF15 are associated with extraskeletal myxoid chondrosarcoma.7

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Martínez-González, J., Cañes, L., Alonso, J., et alNR4A3: A key nuclear receptor in vascular biology, cardiovascular remodeling, and beyond. Int. J. Mol. Sci. 22(21), 11371 (2021).

    2. He, S., Jiang, W., Jiang, B., et alPotential roles of Nr4a3-mediated inflammation in immunological and neurological diseases. Mol. Neurobiol. 61(8), 5958-5973 (2024).

    3. Ohkura, N., Ito, M., Tsukada, T., et alStructure, mapping and expression of a human NOR-1 gene, the third member of the Nur77/NGFI-B family. Biochim. Biophys. Acta 308(3), 205-214 (1996).

    4. Ohkura, N., Ito, M., Tsukada, T., et alAlternative splicing generates isoforms of human neuron-derived orphan receptor-1 (NOR-1) mRNA. Gene 11(1), 79-85 (1998).

    5. Boulet, S., Daudelin, J.-F., Odagiu, L., et alThe orphan nuclear receptor NR4A3 controls the differentiation of monocyte-derived dendritic cells following microbial stimulation. Proc. Natl. Acad. Sci. USA 116(30), 15150-15159 (2019).

    6. Jiang, Y., Feng, Y.-P., Tang, L.-X., et alThe protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway. Biochem. Biophys. Res. Commun. 517(4), 697-702 (2019).

    7. Hisaoka, M., and Hashimoto, H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol. Int. 55(8), 453-463 (2005).